Related Experiment Video
Updated: May 14, 2026

09:52
A Mimic of the Tumor Microenvironment: A Simple Method for Generating Enriched Cell Populations and Investigating Intercellular Communication
Published on: September 20, 2016
Riparian ecosystems in human cancers
Khalid O Alfarouk1, Muntaser E Ibrahim, Robert A Gatenby
1H. Lee Moffitt Cancer Center Tampa, FL, USA.
Evolutionary Applications
|February 12, 2013
Summary
Tumor blood flow creates distinct cancer cell communities, driving genetic diversity within tumors. This vascular network acts as a key evolutionary force shaping cancer
Area of Science:
- Cancer Biology
- Evolutionary Biology
- Tumor Microenvironment Dynamics
Background:
- Cancer's genetic heterogeneity arises from mutations and natural selection.
- Tumor evolution is influenced by interactions between cancer cell traits and their microenvironment.
Purpose of the Study:
- To identify dominant evolutionary forces driving intratumoral heterogeneity.
- To propose the tumor vascular network as a primary cause of this heterogeneity.
Main Methods:
- Analogy between tumor vascularization and desert riparian habitats.
- Examining evolutionary and ecological consequences of variable blood flow.
- Proposing spatial variation in cancer cell phenotypes based on proximity to blood vessels.
Main Results:
- Variable blood flow creates predictable gradients of oxygen and metabolites.
- These gradients act as selection forces, favoring distinct cancer cell populations.
- Distinct cancer cell communities emerge based on distance from blood vessels, similar to riparian zones.
Conclusions:
- Tumor vascular density and blood flow are primary evolutionary drivers of intratumoral heterogeneity.
- A unifying ecological framework can explain cancer cell adaptation and proliferation.
- Understanding vascular influences is key to deciphering cancer's complex evolution.
Related Concept Videos
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
